Over the last few years automation has had a profound impact on the pe
rformance of routine immunoassays in the clinical laboratory, Although
the automation of specialized, labor-intensive methods has been drive
n largely by economic pressures, the development of several new techno
logies have made automation feasible, One of the most significant cont
ributions has been the use of non-isotopic immunometric assays, which
have made it possible to carry out sensitive measurements of circulati
ng peptides within minutes, as compared to days with conventional radi
oimmunoassays, The use of excess reagents in shortened reactions does
impose a requirement for careful design of these procedures, in partic
ular with regard to antibody crossreactivities. Nevertheless, the abil
ity to perform STAT measurements for urgently required substances such
as cardiac markers provides significant benefits in clinical manageme
nt, in addition to the improvements in laboratory economy resulting fr
om automation.